Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) Sees Large Increase in Short Interest

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLFGet Rating) was the target of a large increase in short interest in December. As of December 30th, there was short interest totalling 552,700 shares, an increase of 22.5% from the December 15th total of 451,100 shares. Based on an average daily volume of 400 shares, the short-interest ratio is currently 1,381.8 days.

Ono Pharmaceutical Price Performance

Shares of Ono Pharmaceutical stock opened at $22.60 on Friday. The stock has a market cap of $11.62 billion, a price-to-earnings ratio of 15.48 and a beta of 0.46. The firm’s 50-day moving average is $23.76 and its two-hundred day moving average is $24.79. Ono Pharmaceutical has a 1 year low of $21.00 and a 1 year high of $27.76.

About Ono Pharmaceutical

(Get Rating)

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers OPDIVO intravenous infusions for the treatment of malignant tumors; KYPROLIS for intravenous injection; EMEND capsules/PROEMEND intravenous injections for chemotherapy-induced nausea and vomiting; DEMSER capsules for improvement of the symptoms in patients with pheochromocytoma; and MEKTOVI, VELEXBRU, and ADLUMIZ tablets, as well as BRAFTOVI capsules for malignant tumors.

Further Reading

Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.